Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_assertion type Assertion NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_head.
- NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_assertion description "[Targeting interaction between C/EBPalpha basic region and NF-kappaB p50 may contribute to the therapy of AML and other malignancies expressing C/EBPs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_provenance.
- NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_assertion evidence source_evidence_literature NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_provenance.
- NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_assertion SIO_000772 16254192 NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_provenance.
- NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_assertion wasDerivedFrom befree-20140225 NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_provenance.
- NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_assertion wasGeneratedBy ECO_0000203 NP504813.RAPJKsBxB6qRMIyQe21EJeWL0l3sqtdwI-FVQ2fXKXLS0130_provenance.